"End Stage Recurrent Glioblastoma Treated With a New Noninvasive Non-Co" by Devam Purohit
 

Document Type

Article Presentation

Original Publication Date

2022

Date of Submission

January 2023

Abstract

This presentation focused on the use of a noninvasive oncomagnetic device for glioblastoma. This treatment is special because it is noninvasive and doesn't pose the side effects of chemotherapy or surgery. The study looked at how the oncomagnetic device affected the size of the tumor after it reappeared in the patient's brain after being surgically removed initially. The device was tested on one patient and it was able to reduce his tumor by 31%.

Rights

© The Author(s)

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.